Fosaprepitant
id:
fosaprepitant-178-11499149
title:
Fosaprepitant
text:
Fosaprepitant, sold under the brand names Emend (US) and Ivemend (EU) among others, is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved for medical use in the United States, and in the European Union in January 2008.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Fosaprepitant
date created:
2008-03-15T14:33:45Z
date modified:
2024-09-04T21:04:07Z
main entity:
{"identifier":"Q5473324","url":"https://www.wikidata.org/entity/Q5473324"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/da/Fosaprepitant.svg","width":512,"height":306}
fields total:
13
integrity:
16